Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

Gene Solutions and Pangea Laboratory Establish Strategic Collaboration to Validate Laboratory Developed ctDNA Tests for ...

Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation ...

Transcriptome-based NGS outperforms traditional viral testing with superior sensitivity, detecting viruses including novel ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of Paige Predict, a suite of cutting-edge digital pathology ...

Equipment, training, professional exchange: Thanks to this cooperation, the clinic in Lviv can perform state-of-the-art genetic analyses and detect rare diseases in newborns at an early stage. The ...

Regulatory deregulation and liquid biopsy adoption pushing the rapid growth of the oncology companion diagnostic market. In ...

The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...

The FDA believes that data on MRD and complete response can expedite new drug delivery compared with long-term survival ...

Using CLASSIC, Rice researchers realized that circuits are variable, having multiple pathways to elicit the same outcome.

According to MarketsandMarkets(TM), the Nucleic Acid Isolation and Purification Market is projected to grow from about USD 7.10 billion in 2025 to USD 10.99 billion by 2030, at a CAGR of 9.1%. Browse ...

Strategy is feasible for advanced cancers; 157 regimens were administered to 210 patients, including 103 personalized combos ...